The application of bifidobacteria strains in the practice of pediatricians and general practitioners of family medicine (literature review)
DOI:
https://doi.org/10.15574/SP.2025.3(147).7182Keywords:
children, intestinal microbiome, probiotics, Bifidobacterium breve BR03, Bifidobacterium breve B632Abstract
The human microbiome includes trillions of bacteria, many of them play essential roles in their owner's physiology.
Аim - to systematize data on the effective use of bifidobacteria for various conditions in pediatric patients.
The article discusses the mechanisms of formation of the natural intestinal microbiome from birth, which consists mainly of strains of bacteria that produce lactic acid and short-chain fatty acids. Mechanisms of the influence of microbiota on biological processes in the body are presented for attention. The article reviews modern probiotics - drugs that, according to the definition of the World Food Organization and the World Health Organization, contain live beneficial microorganisms that occur naturally in the intestines, remain viable throughout the gastrointestinal tract, and effectively maintain the balance of the intestinal microbiome when administered in sufficient quantities. The basis of probiotics is made up of homofermentative Lactobacteria, which produce only lactic acid, and heterofermentative Bifidobacteria, which belong to the class Actinobacteria (gram-positive bacteria), order Bifidobacteriales and family Bifidobacteriaceae, and which produce both lactic and acetic acid. Given their large numbers in the intestine, especially in young children, their symbiotic relationship with humans, and their contribution to the breakdown of breast milk oligosaccharides, the article reviews the pharmacological aspects of the use of bifidobacteria, which are considered ideal probiotics for infants.
Conclusions. A unique complex with two strains of Bifidobacterium breve and innovative protection technology is the optimal choice for maintaining intestinal health in infants, preventing colic, improving digestion in the first months of life and during the introduction of complementary foods, as well as for restoring intestinal function in various pathological conditions.
The author declare no conflict of interest.
References
Abbasi A, Aghebati-Maleki A, Yousefi M, Aghebati-Maleki L. (2021). Probiotic intervention as a potential therapeutic for managing gestational disorders and improving pregnancy outcomes. Journal of reproductive immunology. 143: 103244. https://doi.org/10.1016/j.jri.2020.103244; PMid:33186834
Aggarwal N, Breedon AME, Davis CM, Hwang IY, Chang MW. (2020). Engineering probiotics for therapeutic applications: recent examples and translational outlook. Current opinion in biotechnology. 65: 171-179. https://doi.org/10.1016/j.copbio.2020.02.016; PMid:32304955
Aloisio I, Prodam F, Giglione E, Bozzi Cionci N, Solito A, Bellone S et al. (2018). Three-Month Feeding Integration with Bifidobacterium Strains Prevents Gastrointestinal Symptoms in Healthy Newborns. Frontiers in nutrition. 5: 39. https://doi.org/10.3389/fnut.2018.00039; PMid:29888226 PMCid:PMC5980983
Aloisio I, Santini C, Biavati B, Dinelli G, Cencič A, Chingwaru W et al. (2012). Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns. Applied microbiology and biotechnology. 96(6): 1561-1576. https://doi.org/10.1007/s00253-012-4138-5; PMid:22588500
Aloisio I, Santini C, Prodam F et al. (2018). Three-month feeding integration with Bifidobacterium strains prevents gastrointestinal symptoms in healthy newborns. Frontiers in Nutrition. 5: 39. https://doi.org/10.3389/fnut.2018.00039; PMid:29888226 PMCid:PMC5980983
Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, de Roos P et al. (2013). Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 504(7480): 451-455. https://doi.org/10.1038/nature12726; PMid:24226773 PMCid:PMC3869884
Avershina E, Lundgård K, Sekelja M, Dotterud C, Storrø O, Øien T et al. (2016). Transition from infant- to adult-like gut microbiota. Environmental microbiology. 18(7): 2226-2236. https://doi.org/10.1111/1462-2920.13248; PMid:26913851
Bäckhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P et al. (2015). Dynamics and Stabilization of the Human Gut Microbiome during the First Year of Life. Cell host & microbe. 17(5): 690-703. https://doi.org/10.1016/j.chom.2015.04.004; PMid:25974306
Bager P, Wohlfahrt J, Westergaard T. (2008). Caesarean delivery and risk of atopy and allergic disease: meta-analyses. Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 38(4): 634-642. https://doi.org/10.1111/j.1365-2222.2008.02939.x; PMid:18266879
Ballard O, Morrow AL. (2013). Human milk composition: nutrients and bioactive factors. Pediatr Clin North Am. 60(1): 49-74. https://doi.org/10.1016/j.pcl.2012.10.002; PMid:23178060 PMCid:PMC3586783
Beghetti I, Biagi E, Martini S, Brigidi P, Corvaglia L, Aceti A. (2019). Human Milk's Hidden Gift: Implications of the Milk Microbiome for Preterm Infants' Health. Nutrients. 11(12): 2944. https://doi.org/10.3390/nu11122944; PMid:31817057 PMCid:PMC6950588
Béghin L, Tims S, Roelofs M et al. (2021). Fermented infant formula (with Bifidobacterium breve C50 and Streptococcus thermophilus O65) with prebiotic oligosaccharides is safe and modulates the gut microbiota towards a microbiota closer to that of breastfed infants. Clinical Nutrition. 40(3): 778-787. https://doi.org/10.1016/j.clnu.2020.07.012; PMid:32727664
Berg G, Rybakova D, Fischer D, Cernava T, Vergès MC, Charles T et al. (2020). Microbiome definition re-visited: old concepts and new challenges. Microbiome. 8(1): 103. https://doi.org/10.1186/s40168-020-00875-0; PMid:32605663 PMCid:PMC7329523
Bongers ME, van Wijk MP, Reitsma JB, Benninga MA. (2010). Long-term prognosis for childhood constipation: clinical outcomes in adulthood. Pediatrics. 126(1): e156-e162. https://doi.org/10.1542/peds.2009-1009; PMid:20530072
Casiraghi MC, Canzi E, Zanchi R, Donati E, Villa L. (2007). Effects of a synbiotic milk product on human intestinal ecosystem. Journal of applied microbiology. 103(2): 499-506. https://doi.org/10.1111/j.1365-2672.2006.03273.x; PMid:17650211
Cheng L, Kiewiet MBG, Logtenberg MJ, Groeneveld A, Nauta A, Schols HA et al. (2020). Effects of Different Human Milk Oligosaccharides on Growth of Bifidobacteria in Monoculture and Co-culture With Faecalibacterium prausnitzii. Frontiers in microbiology. 11: 569700. https://doi.org/10.3389/fmicb.2020.569700; PMid:33193162 PMCid:PMC7662573
Chen J, Chen X and Ho CL (2021) Recent Development of Probiotic Bifidobacteria for Treating Human Diseases. Front. Bioeng. Biotechnol. 9: 770248. https://doi.org/10.3389/fbioe.2021.770248; PMid:35004640 PMCid:PMC8727868
Chu DM, Ma J, Prince AL, Antony KM, Seferovic MD, Aagaard KM. (2017). Maturation of the infant microbiome community structure and function across multiple body sites and in relation to mode of delivery. Nature medicine. 23(3): 314-326. https://doi.org/10.1038/nm.4272; PMid:28112736 PMCid:PMC5345907
Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. (2016). Human gut colonization may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Scientific reports. 6: 23129. https://doi.org/10.1038/srep23129; PMid:27001291 PMCid:PMC4802384
De Brito Alves JL, de Oliveira Y, Carvalho NNC, Cavalcante RGS, Pereira Lira MM et al. (2019). Gut microbiota and probiotic intervention as a promising therapeutic for pregnant women with cardiometabolic disorders: Present and future directions. Pharmacological research. 145: 104252. https://doi.org/10.1016/j.phrs.2019.104252; PMid:31054952
Derrien M, Alvarez AS, de Vos WM. (2019). The Gut Microbiota in the First Decade of Life. Trends in microbiology. 27(12): 997-1010. https://doi.org/10.1016/j.tim.2019.08.001; PMid:31474424
Derzhprodspozhyvsluzhba Ukrainy. (2019). Informatsiinyi lyst-vkladysh do funktsionalnoho dytiachoho kharchuvannia Simbiozis Bebikol. Vysnovok derzhavnoi sanitarno-epidemiolohichnoi ekspertyzy vid 27.12.2019 r. No.12.2-18-3/28801.
Enomoto T, Sowa M, Nishimori K, Shimazu S, Yoshida A, Yamada K et al. (2014). Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergology international : official journal of the Japanese Society of Allergology. 63(4): 575-585. https://doi.org/10.2332/allergolint.13-OA-0683; PMid:25056226
Erny D, Hrabě de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E et al. (2015). Host microbiota constantly controls maturation and function of microglia in the CNS. Nature neuroscience. 18(7): 965-977. https://doi.org/10.1038/nn.4030; PMid:26030851 PMCid:PMC5528863
Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, Backer J et al. (2008). Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. American journal of physiology. Gastrointestinal and liver physiology. 295(5): G1025-G1034. https://doi.org/10.1152/ajpgi.90227.2008; PMid:18787064
FAO/WHO. (2002). Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario, Canada, April 30 and May 1. URL: http://www.who.int/foodsafety/publications/fs_management/probiotics2/en/.
Fernández L, Langa S, Martín V, Maldonado A, Jiménez E et al. (2013). The human milk microbiota: origin and potential roles in health and disease. Pharmacological research. 69(1): 1-10. https://doi.org/10.1016/j.phrs.2012.09.001; PMid:22974824
Flint HJ, Scott KP, Louis P, Duncan SH. (2012). The role of the gut microbiota in nutrition and health. Nature reviews. Gastroenterology & hepatology. 9(10): 577-589. https://doi.org/10.1038/nrgastro.2012.156; PMid:22945443
Forsythe P, Bienenstock J, Kunze WA. (2014). Vagal pathways for microbiome-brain-gut axis communication. Advances in experimental medicine and biology. 817: 115-133. https://doi.org/10.1007/978-1-4939-0897-4_5; PMid:24997031
Giglione E, Dani C, Comberiati P. (2016). The association of Bifidobacterium breve BR03 and B632 is effective to prevent colics in bottle-fed infants: A pilot, controlled, randomized, and double-blind study. Journal of Clinical Gastroenterology. 50; Suppl 2: S164-S167. https://doi.org/10.1097/MCG.0000000000000705; PMid:27741169
Goldman AS. (2019, Mar). Future Research in the Immune System of Human Milk. J Pediatr. 206: 274-279. https://doi.org/10.1016/j.jpeds.2018.11.024; PMid:30528758
Gomez Arango LF, Barrett HL, Callaway LK, Nitert MD. (2015). Probiotics and pregnancy. Current diabetes reports. 15(1): 567. https://doi.org/10.1007/s11892-014-0567-0; PMid:25398206
Grönlund MM, Lehtonen OP, Eerola E, Kero P. (2011). Influence of mother's intestinal microbiota on gut colonization in the infant. Gut Microbes. 2(4): 227-233. https://doi.org/10.4161/gmic.2.4.16799; PMid:21983067
Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B et al. (2014). Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature reviews. Gastroenterology & hepatology. 11(8): 506-514. https://doi.org/10.1038/nrgastro.2014.66; PMid:24912386
Hou K, Wu ZX, Chen XY et al. (2022). Microbiota in health and diseases. Sig Transduct Target Ther. 7: 135. https://doi.org/10.1038/s41392-022-00974-4; PMid:35461318 PMCid:PMC9034083
Ilmonen J, Isolauri E, Poussa T, Laitinen K. (2011). Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: a randomized placebo-controlled trial. Clinical nutrition (Edinburgh, Scotland). 30(2): 156-164. https://doi.org/10.1016/j.clnu.2010.09.009; PMid:20970896
Klaassens ES, Baak ML, Mekkes NJ, Bongoni R, Schaubeck M. Effect of protein modification in synbiotic infant formula on probiotic metabolic activity and bacterial composition in an infant gut-model. Microbiome Res Rep. 2024; 3: 38. https://doi.org/10.20517/mrr.2024.13; PMid:39421252 PMCid:PMC11480727
Klemenak M, Dolinšek J, Langerholc T, Di Gioia D, Mičetić-Turk D.(2015). Administration of Bifidobacterium Breve Decreases the Production of TNF-α in Children with Celiac Disease. Dig. Dis. Sci. 60: 3386-3392. https://doi.org/10.1007/s10620-015-3769-7; PMid:26134988
Kovatcheva-Datchary P, Arora T. (2013). Nutrition, the gut microbiome and metabolic syndrome. Best practice & research. Clinical gastroenterology. 27(1): 59-72. https://doi.org/10.1016/j.bpg.2013.03.017; PMid:23768553
Koren O, Goodrich JK, Cullender TC, Spor A, Laitinen K, Bäckhed HK et al. (2012). Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell. 150(3): 470-480. https://doi.org/10.1016/j.cell.2012.07.008; PMid:22863002 PMCid:PMC3505857
Kujawska M, Neuhaus K, Huptas C et al. (2024). Exploring the Potential Probiotic Properties of Bifidobacterium breve DSM 32583 - A Novel Strain Isolated from Human Milk. Probiotics & Antimicro. Prot. Online ahead of print. https://doi.org/10.1007/s12602-024-10346-9; PMid:39287748
Kujawska M, Schaubeck M, Hall LJ, Neuhaus K. (2023). Draft genome sequence of Bifidobacterium breve DSM 32583, isolated from human milk. Microbiology resource announcements. 12(11): e0041223. https://doi.org/10.1128/MRA.00412-23; PMid:37815360 PMCid:PMC10652949
Kumar H, Collado MC, Wopereis H, Salminen S, Knol J, Roeselers G. (2020). The Bifidogenic Effect Revisited-Ecology and Health Perspectives of Bifidobacterial Colonization in Early Life. Microorganisms. 8(12): 1855. https://doi.org/10.3390/microorganisms8121855; PMid:33255636 PMCid:PMC7760687
Kuperman AA, Zimmerman A, Hamadia S, Ziv O, Gurevich V, Fichtman B et al. (2020). Deep microbial analysis of multiple placentas shows no evidence for a placental microbiome. BJOG: an international journal of obstetrics and gynaecology. 127(2): 159-169. https://doi.org/10.1111/1471-0528.15896; PMid:31376240
Lawson MAE, O'Neill IJ, Kujawska M, Gowrinadh Javvadi S, Wijeyesekera A, Flegg Z et al. (2020). Breast milk-derived human milk oligosaccharides promote Bifidobacterium interactions within a single ecosystem. The ISME journal. 14(2): 635-648. https://doi.org/10.1038/s41396-019-0553-2; PMid:31740752 PMCid:PMC6976680
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. (2006). Microbial ecology: human gut microbes associated with obesity. Nature. 444(7122): 1022-1023. https://doi.org/10.1038/4441022a; PMid:17183309
Lim ES, Rodriguez C, Holtz LR. (2019). Correction to: Amniotic fluid from healthy term pregnancies does not harbor a detectable microbial community. Microbiome. 7(1): 22. https://doi.org/10.1186/s40168-019-0641-6; PMid:30755267 PMCid:PMC6373139
Lugli GA, Milani C, Turroni F et al. (2020). Investigating bifidobacteria and human milk oligosaccharide composition of lactating mothers. FEMS Microbiology Ecology. 96(5): fiaa049. https://doi.org/10.1093/femsec/fiaa049; PMid:32188978
Market Data Forecast. (2023). Europe Infant Formula Market Report - Trends, Growth & Forecast (2024-2029). URL: https://www.marketdataforecast.com/.
Matamoros S, Gras-Leguen C, Le Vacon F, Potel G, de La Cochetiere MF. (2013). Development of intestinal microbiota in infants and its impact on health. Trends in microbiology. 21(4): 167-173. https://doi.org/10.1016/j.tim.2012.12.001; PMid:23332725
Mercer EM, Ramay HR, Moossavi S, Laforest-Lapointe I, Reyna ME, Becker AB et al. (2024). Divergent maturational patterns of the infant bacterial and fungal gut microbiome in the first year of life are associated with inter-kingdom community dynamics and infant nutrition. Microbiome. 12(1): 22. https://doi.org/10.1186/s40168-023-01735-3; PMid:38326891 PMCid:PMC10848358
Mogna L, Del Piano M, Deidda F, Nicola S, Mogna G. (2014). Capability of the two microorganisms Bifidobacterium breve B632 and Bifidobacterium breve BR03 to colonize the intestinal microbiota of children. Journal of Clinical Gastroenterology. 48; Suppl 1: S37-S39. https://doi.org/10.1097/MCG.0000000000000232; PMid:25291123
Mogna L, Del Piano M, Nicola S, Mogna G. (2012). Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains (LP01, LP02, LR04, LR06, LPS01, LDD01, BR03, B632). Journal of Clinical Gastroenterology. 46; Suppl: S29-S32. https://doi.org/10.1097/MCG.0b013e31826852b7; PMid:22955353
Nicola S, Del Piano M, Mogna G. (2010). Interaction between probiotics and human immune cells: the prospective anti-inflammatory activity of Bifidobacterium breve BR03. Agro FOOD Industry Hi Tech. 21(2): S44-S47.
Nielsen IQ. (2023). US Infant Formula Market: Year in Review 2022. URL: https://nielseniq.com/.
Nuriel-Ohayon M, Neuman H, Ziv O, Belogolovski A, Barsheshet Y, Bloch N et al. (2019). Progesterone Increases Bifidobacterium Relative Abundance during Late Pregnancy. Cell reports. 27(3): 730-736.e3. https://doi.org/10.1016/j.celrep.2019.03.075; PMid:30995472
Parhi P, Dash B, Misra N. (2022). Growth and survival of Bifidobacterium breve and Bifidobacterium longum in various sugar systems with fructooligosaccharide supplementation. Journal of Food Science and Technology. 59(10): 3775-3786. https://doi.org/10.1007/s13197-022-05361-z; PMid:36193365 PMCid:PMC9525548
Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I et al. (2006). Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 118(2): 511-521. https://doi.org/10.1542/peds.2005-2824; PMid:16882802
Poltavska OA, Kovalenko NK. (2208). Bifidobakterii i ix biolohichni vlastyvosti. Mikrobiolohiia i biotekhnolohiia. 1(2): 8-17. https://doi.org/10.18524/2307-4663.2008.1(2).103689
Rackaityte E, Halkias J, Fukui EM, Mendoza VF, Hayzelden C, Crawford ED et al. (2020). Viable bacterial colonization is highly limited in the human intestine in utero. Nature medicine. 26(4): 599-607. https://doi.org/10.1038/s41591-020-0761-3; PMid:32094926 PMCid:PMC8110246
Robles-Vera I, Toral M, de la Visitación N, Sánchez M, Gómez-Guzmán M, Romero M et al. (2020). Probiotics Prevent Dysbiosis and the Rise in Blood Pressure in Genetic Hypertension: Role of Short-Chain Fatty Acids. Molecular nutrition & food research. 64(6): e1900616. https://doi.org/10.1002/mnfr.201900616; PMid:31953983
Salminen S, Szajewska H, Heine RG, Agostoni C, Braegger C. (2020). Infant formula supplemented with biotics: Current knowledge and future perspectives. Nutrients. 12(7): 1952. https://doi.org/10.3390/nu12071952; PMid:32629970 PMCid:PMC7400136
Salvatore S, Hauser B, Vandenplas Y. (2018). The use of semi-elemental formulas in pediatric gastroenterology. Nutrition in Clinical Practice. 33(6): 770-780. https://doi.org/10.1002/ncp.10150.
Senn V, Bassler D, Choudhury R, Scholkmann F, Righini-Grunder F et al. (2020). Microbial Colonization from the Fetus to Early Childhood-A Comprehensive Review. Frontiers in cellular and infection microbiology. 10: 573735. https://doi.org/10.3389/fcimb.2020.573735; PMid:33194813 PMCid:PMC7661755
Shao Y, Forster SC, Tsaliki E, Vervier K, Strang A, Simpson N et al. (2019). Stunted microbiota and opportunistic pathogen colonization in caesarean-section birth. Nature. 574(7776): 117-121. https://doi.org/10.1038/s41586-019-1560-1; PMid:31534227 PMCid:PMC6894937
Sherwin E, Dinan TG, Cryan JF. (2018). Recent developments in understanding the role of the gut microbiota in brain health and disease. Annals of the New York Academy of Sciences. 1420(1): 5-25. https://doi.org/10.1111/nyas.13416; PMid:28768369
Silva YP, Bernardi A, Frozza RL. (2020). The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Frontiers in endocrinology. 11: 25. https://doi.org/10.3389/fendo.2020.00025; PMid:32082260 PMCid:PMC7005631
Simone M, Deidda F, Paoletti C, Mogna G. (2014). The probiotic Bifidobacterium breve B632 inhibited the growth of Enterobacteriaceae within colicky infant microbiota cultures. BioMed Research International. 2014: Article ID 301053. https://doi.org/10.1155/2014/301053; PMid:25309908 PMCid:PMC4163384
Stinson LF, Boyce MC, Payne MS, Keelan JA. (2019). The Not-so-Sterile Womb: Evidence That the Human Fetus Is Exposed to Bacteria Prior to Birth. Frontiers in microbiology. 10: 1124. https://doi.org/10.3389/fmicb.2019.01124; PMid:31231319 PMCid:PMC6558212
Stuivenberg GA, Burton JP, Bron PA, Reid G. (2022). Why Are Bifidobacteria Important for Infants? Microorganisms. 10(2): 278. https://doi.org/10.3390/microorganisms10020278; PMid:35208736 PMCid:PMC8880231
Stuivenberg GAM, van der Meulen M, van Vliet IM. (2022). Why Are Bifidobacteria Important for Infants? Microorganisms. 10(2): 278. https://doi.org/10.3390/microorganisms10020278; PMid:35208736 PMCid:PMC8880231
Sun S, Luo L, Liang W, Yin Q, Guo J, Rush AM et al. (2020). Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade. Proceedings of the National Academy of Sciences of the United States of America. 117(44): 27509-27515. https://doi.org/10.1073/pnas.1921223117; PMid:33077598 PMCid:PMC7959554
Taft DH, Liu J, Maldonado-Gomez MX, Akre S, Huda MN, Ahmad SM et al. (2018). Bifidobacterial Dominance of the Gut in Early Life and Acquisition of Antimicrobial Resistance. mSphere. 3(5): e00441-18. https://doi.org/10.1128/mSphere.00441-18; PMid:30258040 PMCid:PMC6158511
Thibault H, Aubert-Jacquin C, Goulet O. (2004). Effects of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococcus thermophilus 065) on acute diarrhea in healthy infants. Journal of pediatric gastroenterology and nutrition. 39(2): 147-152. https://doi.org/10.1097/00005176-200408000-00004; PMid:15269618
Tsilingiri K, Rescigno M. (2013). Postbiotics: what else? Beneficial microbes. 4(1): 101-107. https://doi.org/10.3920/BM2012.0046; PMid:23271068
Tufail MA, Schmitz RA. (2025). Exploring the Probiotic Potential of Bacteroides spp. Within One Health Paradigm. Probiotics and antimicrobial proteins. 17(2): 681-704. https://doi.org/10.1007/s12602-024-10370-9; PMid:39377977 PMCid:PMC11925995
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. (2006). An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444(7122): 1027-1031. https://doi.org/10.1038/nature05414; PMid:17183312
Turroni F, Peano C, Pass DA, Foroni E, Severgnini M, Claesson MJ et al. (2012). Diversity of bifidobacteria within the infant gut microbiota. PloS one. 7(5): e36957. https://doi.org/10.1371/journal.pone.0036957; PMid:22606315 PMCid:PMC3350489
Vallianou N, Stratigou T, Christodoulatos GS, Tsigalou C, Dalamaga M. (2020). Probiotics, Prebiotics, Synbiotics, Postbiotics, and Obesity: Current Evidence, Controversies, and Perspectives. Current obesity reports. 9(3): 179-192. https://doi.org/10.1007/s13679-020-00379-w; PMid:32472285
Van den Akker CHP, van Goudoever JB, Shamir R, Domellöf M, Embleton ND, Hojsak I et al. (2020). Probiotics and Preterm Infants: A Position Paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics. Journal of pediatric gastroenterology and nutrition. 70(5): 664-680. https://doi.org/10.1097/MPG.0000000000002655; PMid:32332478
Viswanathan K, Muthusamy S. (2022). Review on the current trends and future perspectives of postbiotics for developing healtheir foods. eFood. 3: e47. https://doi.org/10.1002/efd2.47
Wilcox CR, Jones CE. (2018). Beyond Passive Immunity: Is There Priming of the Fetal Immune System Following Vaccination in Pregnancy and What Are the Potential Clinical Implications? Frontiers in immunology. 9: 1548. https://doi.org/10.3389/fimmu.2018.01548; PMid:30061881 PMCid:PMC6054988
Wong CB, Iwabuchi N, Xiao J-Z. (2019). Exploring the Science behind Bifidobacterium breve M-16V in Infant Health. Nutrients. 11(8): 1724. https://doi.org/10.3390/nu11081724; PMid:31349739 PMCid:PMC6723912
Woodd SL, Montoya A, Barreix M, Pi L, Calvert C, Rehman AM et al. (2019). Incidence of maternal peripartum infection: A systematic review and meta-analysis. PLoS medicine. 16(12): e1002984. https://doi.org/10.1371/journal.pmed.1002984; PMid:31821329 PMCid:PMC6903710
Xiao L, Zhao F. (2023). Microbial transmission, colonization and succession: from pregnancy to infancy. Gut. 72(4): 772-786. https://doi.org/10.1136/gutjnl-2022-328970; PMid:36720630 PMCid:PMC10086306
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
